BSECompany Update10 Aug 2026 · 10 Aug 2026, 04:39 pm

Intimation of an analyst and investor Meet under Regulation 30 of SEBI (LODR), Regulations, 2015.

Bharat Parenterals Ltd · 541096

✦ AI SummaryMgmt Change

Bharat Parenterals Ltd has announced an analyst and investor meet under Regulation 30 of SEBI (LODR) on August 13, 2026, at Emkay Global Financial Services Ltd in Mumbai.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

e9235f75-5824-44f8-a54f-577bc3cc0e31.pdf

pdf

Download →
View document text
Date: August 10, 2026 Corporate Relations Department BSE Limited Floor 25, P.J. Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 541096 Dear Sir/Madam, Subject: Intimation of Analyst and Investor meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 In accordance with Regulation 30 read with Schedule III of the SEBI LODR (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that representatives of the Company will be interacting with analysts and investors in a physical one to one as well as group meeting as per the following schedule: Date & Time Type of Organizer/Host Location Mode Interaction August 13, 2026 Investors /Analysts Emkay Global Financial Mumbai Physical from 10:00 AM Meetings Services Ltd. During the aforesaid Interaction, no unpublished price-sensitive information (UPSI) will be shared by the company or its Representatives. The aforesaid investor meetings are subject to end minute changes, due to exigencies on the part of Investor(s) or the Company. The aforementioned information is also available on the Company’s website at www.bplindia.in We request you to take the above on record and the same be treated as compliance under the applicable regulation(s) under the SEBI LODR (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and record. Thanking You, Yours Faithfully, For, Bharat Parenterals Limited Mr. Sharmin Soni Company Secretary & Compliance Officer ICSI M.No: A-75694 Place: Vadodara